SEC Form 4 · accession 0001171843-17-006832
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Daly
Officer — Chief Executive Officer · Director
Period of report
Nov 7, 2017
Accepted (ET)
Nov 9, 2017 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $1.12 | Nov 7, 2017 | A | 100,000 | A | Nov 7, 2017 | Nov 7, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Represents a discretionary grant to Employee. The options vest quarterly on 2/718, 5/7/18, 8/7/18, and 11/7/18.